The Clinical Trials Abundance blog

Is clinical trial abundance having a moment?

A “what we’re reading” spotlight.

Published on The Abundance and Growth Blog • Oct 15

September 2026

The clinical trial bottlenecks game

Where’s the bottleneck in curing diseases? I designed a game to find out.

Sep 25 • Saloni Dattani

38

3

8

Clinical Trial Abundance in the New York Times

Two new articles reveal what’s wrong with the US clinical trial system and how policymakers can fix it

Sep 11 • Adam Kroetsch

12

3

August 2026

Google Maps for Medicines

A new tool to help you navigate drug approval routes in lower and middle income countries

Aug 25 • Enlli McAleese

16

1

5

Medical innovation needs you

Saloni's TED talk on clinical innovation was released today.

Published on The Works in Progress Newsletter • Aug 17

Cure all diseases

Few people know how much medicine has progressed in their lifetimes. Fewer know how much faster it could be progressing.

Published on The Works in Progress Newsletter • Aug 12

July 2026

Market shaping and trial design belong together

Two birds, one trial

Jul 14 • Witold Więcek

24

9

5

June 2026

Why were Covid vaccine trials so fast?

The timeline to develop coronavirus vaccines blew many predictions out of the water.

Jun 26 • Saloni Dattani

98

4

29

The new HHS trial reforms are more ambitious than they look

A Deeper Dive into Operation TrialBlazer

Jun 23 • Adam Kroetsch

12

4

The US moves to reclaim the therapeutic pipeline

A welcome move from the FDA and HHS

Jun 22 • Ruxandra Teslo

14

5

1

Manufacturing requirements are killing cell and gene therapy

Some of the most promising drugs are bottlenecked by a "boring" but incredibly important problem

Jun 10 • Ruxandra Teslo and Amol Punjabi

30

1

2

Clinical trial innovations don't scale. Here's why, and how to fix it.

A Policy Agenda for Efficient, Abundant Clinical Trials

Published on Policy and Practice • Jun 8